IPI-549
Showing 1 - 25 of 117
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head and Neck Carcinoma Trial in La Jolla (IPI-549)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +7 more
- IPI-549
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Jul 20, 2022
Advanced Solid Tumors (Part A/B/C/D), NSCLC (Part E), Melanoma (Part E) Trial in United States (IPI-549 (eganelisib), Nivolumab)
Active, not recruiting
- Advanced Solid Tumors (Part A/B/C/D)
- +7 more
- IPI-549 (eganelisib)
- Nivolumab
-
San Diego, California
- +10 more
Apr 1, 2022
Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)
Active, not recruiting
- Bladder Cancer
- +3 more
- IPI-549 (eganelisib)
- +2 more
-
Fort Wayne, Indiana
- +28 more
Apr 1, 2022
Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)
Active, not recruiting
- Breast Cancer
- Renal Cell Carcinoma
- IPI-549 (eganelisib)
- +3 more
-
Chandler, Arizona
- +23 more
Apr 1, 2022
NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)
Terminated
- Non-small Cell Lung Cancer
- REGN2810/ipi
- +2 more
-
Saint Petersburg, Florida
- +2 more
Oct 22, 2022
Healthy Trial in Groningen (CG-549)
Completed
- Healthy
-
Groningen, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
May 24, 2022
Endoscopy Trial in Istanbul (gastroscopy)
Recruiting
- Endoscopy
- gastroscopy
-
Istanbul, Gaziosmanpaşa, TurkeyGaziosmanpaşa TREH
Apr 13, 2023
Integrated Pulmonary Index asDeterminate of Weaning Success
Withdrawn
- Respiratory Insufficiency
-
Chicago, IllinoisRush University Medical Center- Rush Children's Hospital
Dec 23, 2022
Immune-related Adverse Event, Diarrhea, Advanced Melanoma Trial in Edmonton (Mesalamine)
Not yet recruiting
- Immune-related Adverse Event
- +3 more
-
Edmonton, Alberta, CanadaCross Cancer Institute
Dec 15, 2022
Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)
Recruiting
- Metastatic Urothelial Carcinoma
- Ipilimumab
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Family Planning, Contraception, PostPartum Trial in Wailuku, Chicago, New York (LINCC intervention - enable co-schedule feature)
Recruiting
- Family Planning
- +2 more
- LINCC intervention - enable co-schedule feature
-
Wailuku, Hawaii
- +4 more
Nov 18, 2022
Monitored Anesthesia Care, Respiratory Monitoring Trial in Istanbul (Integrated Pulmonary Index (IPI) monitoring, propofol,
Completed
- Monitored Anesthesia Care
- Respiratory Monitoring
- Integrated Pulmonary Index (IPI) monitoring
- +2 more
-
Istanbul, Pendik, TurkeyMarmara University School of Medicine
Mar 14, 2022
Monitored Anesthesia Care, Respiratory Monitoring Trial in Istanbul (Integrated Pulmonary Index (IPI) monitoring, propofol,
Completed
- Monitored Anesthesia Care
- Respiratory Monitoring
- Integrated Pulmonary Index (IPI) monitoring
- +2 more
-
Istanbul, Pendik, TurkeyMarmara University School of Medicine
Mar 14, 2022
Lymphoma, B-Cell Trial in San Antonio (R-Chop and Roflumilast)
Not yet recruiting
- Lymphoma, B-Cell
- R-Chop and Roflumilast
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
Mar 31, 2023
Frontline of ASCT in High-risk DLBCL
Recruiting
- Diffuse Large B Cell Lymphoma
-
Beijing, Beijing, ChinaPeking University People's Hospital
Apr 26, 2023
Breast Cancer, Chemo-Related Cognitive Impairment Trial in Miami (Individualized Piano Keyboard Instruction)
Completed
- Breast Cancer
- Chemotherapy-Related Cognitive Impairment
- Individualized Piano Keyboard Instruction
-
Miami, FloridaUniversity of Miami
Jun 9, 2023
Integrated Pulmonary Index During Cesarean Section Under Spinal
Not yet recruiting
- Intraoperative Hypotension
- Capnometry Monitorization
- (no location specified)
Feb 11, 2022
Monitored Anesthesia Care Trial in Samsun (Smart Capnography™, Microstream®)
Completed
- Monitored Anesthesia Care
- Smart Capnography™, Microstream®
-
Samsun, TurkeySamsun Research and Education Hospital
Apr 26, 2022
DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)
Recruiting
- DLBCL Germinal Center B-Cell Type
- Selinexor
- +5 more
-
Guangzhou, Guangdong, China
- +5 more
Aug 16, 2022
Thoracic Surgery Patients
Completed
- Postoperative Complications
- Monitoring
- integrated pulmonary index monitor
-
Adana, TurkeyMediha Türktan
May 10, 2022
Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
-
Athens, GreeceLocal Institution - 0001
Oct 26, 2022
Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant
Recruiting
- Atypical Teratoid Rhabdoid Tumor
- +6 more
- Tazemetostat
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2023
Chronic Lymphocytic Leukemia Trial in Boston (IPI-145, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- IPI-145
- +3 more
-
Boston, Massachusetts
- +1 more
Mar 10, 2022
Cranial Bone-augmented Jaw: A Feasibility Study
Active, not recruiting
- Severely Atrophic Jaw
- cone-beam computed tomography (CBCT)
-
Bruges, BelgiumDivision of Maxillofacial Surgery, Department of Surgery, AZ Sin
Feb 23, 2022